Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Carlsmed (CARL) Revenue (2024 - 2025)

Carlsmed's Revenue history spans 2 years, with the latest figure at $15.2 million for Q4 2025.

  • For Q4 2025, Revenue rose 61.19% year-over-year to $15.2 million; the TTM value through Dec 2025 reached $49.7 million, changed N/A, while the annual FY2025 figure was $50.5 million, 85.94% up from the prior year.
  • Revenue reached $15.2 million in Q4 2025 per CARL's latest filing, up from $13.1 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $15.2 million in Q4 2025 to a low of $6.1 million in Q2 2024.